- cafead   Jun 27, 2024 at 11:32: AM
via
article source
- Pfizer dominates the pneumococcal vaccine market.
- However, Merck has obtained approval for a pneumococcal vaccine
- Merck's new medication could become the new top seller for this indication.
article source